Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of 3 combinations of
naltrexone and bupropion SR compared to naltrexone alone, bupropion SR alone or placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Orexigen Therapeutics, Inc
Treatments:
Bupropion Bupropion hydrochloride, naltrexone hydrochoride drug combination Naltrexone